DiaSys introduces dedicated respons and BioMajesty JCA-BM6010/C kits for Procalcitonin FS
After two years of successful marketing of Procalcitonin FS, dedicated kits for the DiaSys respons systems and BioMajesty JCA-BM6010/C will be available from October 2022. Procalcitonin FS offers a reliable alternative, when time matters in sepsis management.